Overview
Akihiro Miyazaki practices in Sapporo, Japan. Mr. Miyazaki is rated as an Experienced expert by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Oral Squamous Cell Carcinoma, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Goldenhar Disease.
His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hairy Cell Leukemia (HCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Oral Squamous Cell CarcinomaMr. Miyazaki isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Advanced
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Tongue CancerMr. Miyazaki isAdvanced. Learn about Tongue Cancer.
- Experienced
- Acrofacial Dysostosis Rodriguez TypeMr. Miyazaki isExperienced. Learn about Acrofacial Dysostosis Rodriguez Type.
- Acrofrontofacionasal Dysostosis SyndromeMr. Miyazaki isExperienced. Learn about Acrofrontofacionasal Dysostosis Syndrome.
- Crouzon SyndromeMr. Miyazaki isExperienced. Learn about Crouzon Syndrome.
- FibromatosisMr. Miyazaki isExperienced. Learn about Fibromatosis.
- Goldenhar DiseaseMr. Miyazaki isExperienced. Learn about Goldenhar Disease.
- Hairy Cell Leukemia (HCL)Mr. Miyazaki isExperienced. Learn about Hairy Cell Leukemia (HCL).